Acorda Therapeutics Announces Exercise of Option by Underwriter

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the “Company”) announced today that Deutsche Bank Securities Inc., as underwriter of the Company’s common stock offering that was announced on August 7, 2008, has exercised its entire option to purchase an additional 600,000 shares of common stock at the public offering price of $28.50 per share. The exercise of the option increases the size of the offering to an aggregate of 4,600,000 shares of common stock.

Back to news